Rahim, N. (2025) “Bispecific CAR-T vs. BCMA-Specific CAR-T: Advancing Treatment for Relapsed/Refractory Multiple Myeloma”, Highlights in Science, Engineering and Technology, 153, pp. 42–47. doi:10.54097/wvmnsh51.